SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions

BOULDER, Colo. -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions (M&A). “We are thrilled to welcome Steve to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His extensive advisory and [...]

Thomas Scientific Finalizes Supplier Agreement with City and County of San Francisco

It’s the second significant award in a month for North America’s largest pure-play distributor serving science, building off what has been a strong 2021. SWEDESBORO, NEW JERSEY and SAN FRANCISCO, CALIFORNIA – In its second notable contract award over the past four weeks, Thomas Scientific has entered into a 5-year agreement with the City and County [...]

OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™

Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – OpenEye Scientific and Specifica, Inc., today announced they are releasing jointly developed software to help antibody engineers and bioinformaticians at pharmaceutical and biotechnology companies advance antibody discovery by identifying diverse antibody sets with better properties for downstream therapeutics [...]

New Wastewater Diagnostic Kit for SARS-CoV-2 Testing including Identification of Omicron Variant

SARS-CoV-2 Testing including Identification of Omicron Variant  December 02, 2021 Eurofins Technologies announces the launch of the VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits to provide an efficient solution for SARS-CoV-2 detection in wastewater, including the Omicron variant of concern. Wastewater-based epidemiology has become an important approach in order to comprehensively monitor the profile [...]

Meridian Bioscience Announces Retirement of CFO Bryan Baldasare

CINCINNATI  -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021.  The Company is engaging an executive search firm in the recruitment of a new [...]

On December 1, 2021, the production site in Laage formerly belonging to Flamm Aerotec GmbH will see a new owner moving in: Miltenyi Biotec B.V. & Co. KG. With this acquisition, this globally operating biomedical company is expanding its capacities in the State of Mecklenburg-West Pomerania and is planning to create new jobs in the medium term. The site measuring 51,000 square meters is ideally situated near the Rostock-Laage Airport and can be easily accessed from Miltenyi Biotec’s production site in Teterow. “We are pleased that Miltenyi Biotec will succeed us, move onto these premises and to give the site new prospects,” says Stefan Koch, Managing Director of Flamm Aerotec. Flamm Aerotec manufactured parts for the automotive supplier industry in Laage until December 31, 2020. “Laage is well-situated for us to scale up our production capacities in the medium term and will accommodate new, urgently needed expansion areas for our production location in Teterow,” says Stefan Miltenyi, Miltenyi Biotec founder. In Teterow, some 500 Miltenyi Biotec employees produce and develop innovative medical technology and novel therapies for cancer treatment. To meet the high global demand for these products, the site is undergoing expansion. Miltenyi Biotec currently has 50 positions to fill in Research and Production. Miltenyi Biotec is not only looking for specialists with expertise in the natural sciences, but also those seeking a career change from other industries. About Miltenyi Biotec: Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 3,500 employees in 28 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health. To find out more, go to www.miltenyibiotec.com. Contact: Holger Bülow, Corporate Communications E-mail: corpcom@miltenyi.com Phone: +49 2204 8306-0 About Flamm Aerotec: Flamm Aerotec, a subsidiary of the Mubea Group with its head office in Attendorn, is a supplier of the international airspace industry and produces modules and components at its sites in Schwerin and Ergene, Turkey.

EMERYVILLE, Calif. and MARSEILLE, France -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and develops antibodies for immunotechnology therapeutics and research, today announced the acquisition of the Berkeley Lights Beacon® system via a TechAccess subscription to help further its mission of helping its customers [...]

PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region

Strategic hire will expand Company’s commercial presence in key geography MENLO PARK, Calif. — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General Manager for the company’s Asia-Pacific region. Jason will be responsible for leading and developing PacBio’s commercial team in Asia-Pacific as the company continues to expand its reach in the [...]

BD Issues 2021 Global Inclusion, Diversity and Equity Report

Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for All FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report. The report, titled "Together We Advance ID&E," [...]

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enroll 4,000 patients from approximately 30 sites across North America, Europe, and Latin America BOSTON and [...]

Ecolab Closes on Purchase of Purolite

ST. PAUL, Minn. -- Ecolab Inc. has closed on its previously announced acquisition of Purolite, a leading and fast-growing global provider of high-end ion exchange resins for the separation and purification of solutions for pharmaceutical and industrial applications. Headquartered in King of Prussia, PA, Purolite operates in more than 30 countries, with expected 2021 sales [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access

Register to Subscribe Login for Access

Lost your password? Register